BASF hires production in Ludwigshafen: 180 employees affected

BASF hires production in Ludwigshafen: 180 employees affected

At the Ludwigshafen location, significant changes are imminent: In 2025, the production of obesity, cyclododecanon (CDON) and Cyclopentanon (CPON) will be set. This decision is part of a gradual process to adapt the production structures to increase economic performance.

The closure of these production facilities will affect the local workforce, since around 180 employees could lose their workplace. However, BASF has assured that the employees concerned are actively supported in order to find new employment opportunities within the company.

The need for these measures results from the changing market situation. According to Dr. Stephan Kothrade, member of the Board of Directors and Chief Technology Officer of BASF SE, is essential to secure the profitability of the entire value chain. The group will be in close contact with the customers to keep the effects of the closure as low as possible.

production and use of the chemicals concerned

obesic acid, cyclododecanon and cyclopentanon play a significant role in the chemical industry. Obesic acid is often used to produce polyamides, polyurethanes and adhesives. Cyclododecanon, on the other hand, is an important raw material for the production of Lauryllactam, a pre -product of the high -performance plastic Polyamide 12 (PA 12). These special plastics are used in many industries, from automotive to the electronics industry.

cyclopentanon is also used in various chemical processes, including in the production of pesticides and pharmaceutical active ingredients. It is also used in the production of semiconductors and special fragrances. The closure of these production lines not only means a loss of jobs, but also affects various supply chains and numerous industrial applications.

In particular, reduced obesity production was discontinued in February 2023 after adapting the composite structures at the Ludwigshafen location. So far, the remaining obesity production has been continued to ensure continuous raw material supply for cdons and CPOons. The complete setting of these productions will now be made after a close exchange with the customers.

The closings are part of a more comprehensive strategy for transformation from the Ludwigshafen location. Dr. Katja Scharpwinkel, who acts as a working director and location manager, emphasizes that the goal is to develop a long -term concept for the future of the location. The employees concerned should receive support in order to find new perspectives within the BASF group as soon as possible.

These developments at BASF reflect the challenges with which the chemistry industry is confronted worldwide. The progressive globalization and dynamic market conditions require continuous adjustments to remain competitive. The Ludwigshafen location is an important center for BASF, and the measures taken should help to ensure the sustainable development and profitability in the region in the long term.